Source - SMW
Concepta has announced a positive update on the launch of its proprietary myLotus product in its first international market, China. 

The company has signed an additional two three-year exclusive distribution agreements for myLotus with Huanzhong Biotech and Wanma Technology Co in China. 

The distribution agreement with Huanzhong Biotech Ltd will cover the province of Hebei near Beijing, while Wanma Technology Co  will cover the Shanghai area. 

It said: 'Alongside ThinkBrio, which distributes the myLotus product to Beijing and Lianoing, these two agreements will expand Concepta's product offering in China to target a total population of 147 million people across these regions.'

Concepta also said it had completed a preliminary hospital evaluation process in China to extend the use of myLotus into early pregnancy monitoring. 

It said:'Based on recent positive hospital evaluation results, the Company's new distributors, Huanzhong Biotech Ltd and Wanma Technology will be the first to target the "early pregnancy" group alongside the "unexplained infertility" target group. 

'There is a total target market of 2.3 million women a year across the Hebei, Beijing, Lianoing and Shanghai areas for early pregnancy monitoring.'

Chief executive Erik Henau  said: 'We are delighted to add these new distributors to our network in China, following the Company's excellent preliminary hospital evaluation results. 

'Following the final conclusion of the evaluation, an event will be held in China for a large number of potential distributors where we will exhibit the myLotus product. 

'We expect to announce further distribution agreement signings following this event.'


At 9:46am: (LON:CPT) Concepta Plc Ord 2.5p share price was +0.75p at 10p